Your browser doesn't support javascript.
loading
Tapentadol Safety and Patient Characteristics Associated with Treatment Discontinuation in Cancer Therapy: A Retrospective Multicentre Study in Japan.
Iwaki, Michihiro; Kessoku, Takaomi; Kanamori, Taro; Abe, Kentaro; Takeno, Nobuhiro; Kawahara, Ryoko; Fujimoto, Taisuke; Igarashi, Takashi; Kumakura, Yasutomo; Suzuki, Naoki; Kamiya, Kouhei; Suzuki, Naoto; Tagami, Keita; Saeki, Tomoya; Mawatari, Hironori; Sakurai, Hiroki; Higashibata, Takahiro; Hirohashi, Takeshi; Nakajima, Atsushi; Ichikawa, Yasushi; Ishiki, Hiroto.
Afiliación
  • Iwaki M; Department of Palliative Medicine, Yokohama City University Hospital, Yokohama, Japan.
  • Kessoku T; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kanamori T; Department of Palliative Medicine, Yokohama City University Hospital, Yokohama, Japan.
  • Abe K; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Takeno N; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Kawahara R; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Fujimoto T; Department of Pharmacy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Igarashi T; Department of Palliative Care, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kumakura Y; Department of Hospital Pharmacy, National Cancer Centre Hospital East, Chiba, Japan.
  • Suzuki N; Department of Hospital Pharmacy, National Cancer Centre Hospital East, Chiba, Japan.
  • Kamiya K; Department of Anaesthesiology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
  • Suzuki N; Department of Palliative Medicine, Yamagata Prefectural Central Hospital, Yamagata, Japan.
  • Tagami K; Department of Palliative Medicine, Yamagata Prefectural Central Hospital, Yamagata, Japan.
  • Saeki T; Laboratory of Oncology, Pharmacy Practice and Sciences, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.
  • Mawatari H; Department of Palliative Medicine, Tohoku University School of Medicine, Sendai, Japan.
  • Sakurai H; Department of Hospital Pharmacy, Yokohama Minami Kyousai Hospital, Yokohama, Kanagawa, Japan.
  • Higashibata T; Department of Palliative and Supportive Care, Yokohama Minami Kyousai Hospital, Yokohama, Kanagawa, Japan.
  • Hirohashi T; Department of Palliative Medicine, Toranomon Hospital, Tokyo, Japan.
  • Nakajima A; Palliative Care Team, Department of General Medicine and Primary Care, University of Tsukuba Hospital, Tsukuba, Japan.
  • Ichikawa Y; Department of Palliative Care, Eiju General Hospital, Tokyo, Japan.
  • Ishiki H; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Pain Ther ; 10(2): 1635-1648, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34581982
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pain Ther Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pain Ther Año: 2021 Tipo del documento: Article País de afiliación: Japón